SCHEMBL5068100

SCHEMBL5068100

O=C(O)c1ccc(-n2cccn2)c(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.52
ALDH1A1 P00352 6/20 0.50
MEN1 O00255 5/20 0.50
MAPT P10636 5/20 0.50
KMT2A Q03164 5/20 0.50
F2 P00734 1/20 0.49
PLAU P00749 1/20 0.49
KLKB1 P03952 1/20 0.49
ELANE P08246 1/20 0.49
TSHR P16473 1/20 0.47
HTT P42858 2/20 0.46
MDM2 Q00987 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
KDM4E B2RXH2 1/20 0.45
GAA P10253 1/20 0.45
G6PD P11413 1/20 0.45
RORC P51449 2/20 0.43
CYP2C8 P10632 1/20 0.42
CYP2C9 P11712 1/20 0.42
KCNH2 Q12809 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1275221 0.88 ALDH1A1 (0.50) LMNAALDH1A1MEN1MAPTKMT2A
SCHEMBL11494447 0.87 KMT2A (0.49) LMNAALDH1A1MEN1MAPTKMT2A
SCHEMBL18270149 0.85 LMNA (0.52) LMNAALDH1A1MEN1MAPTKMT2A
SCHEMBL24528617 0.82 MYC (0.54) LMNAALDH1A1MEN1MAPTKMT2A
SCHEMBL5063290 0.80 ALDH1A1 (0.47) LMNAALDH1A1MEN1MAPTKMT2A
SCHEMBL16869706 0.78 LMNA (0.49) LMNAALDH1A1MEN1MAPTKMT2A
SCHEMBL11487266 0.78 CA2 (0.49) LMNAALDH1A1MEN1MAPTKMT2A
SCHEMBL16911659 0.78 MEN1 (0.55) LMNAALDH1A1MEN1MAPTKMT2A
SCHEMBL4254004 0.77 KMT2A (0.65) LMNAALDH1A1MEN1MAPTKMT2A
SCHEMBL30055522 0.77 NOTUM (0.56) LMNAALDH1A1MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161294-A1 Urea derivative, medicinal composition containing the same, and medicinal use of these KISSEI PHARMACEUTICAL CO., LTD. (JP) 2008-07-03 US disclosed
EP-1867639-A1 UREA DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2007-12-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161294-A1 Urea derivative, medicinal composition containing the same, and medicinal use of these AVPR2, UTS2R, GPR119 LMNA 3989/4885ALDH1A1 1758/4885MEN1 1124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.